Monotherapy in Newly Diagnosed Epilepsy: Levetiracetam versus Standard Anticonvulsants

Shifting Valproic Acid to Levetiracetam in Women of Childbearing Age With Epilepsy: A Retrospective Investigation and Review of the Literature

“…Moreover, both congenital malformations and cognitive impairment have been reported to be dose dependent (12,17,18). Levetiracetam, a new antiepileptic drug with a low-risk for teratogenicity (19), has been proven to be effective for juvenile myoclonic epilepsy (20), and to have a similar efficacy in the treatment of new-onset epilepsy to VPA (21). Its use has also been suggested in pregnancy (22).…”